Skip to main content

Weather Alert

Hurricane Helene is severely impacting Quest locations across the Southeast. We ask that patients please double check your appointment status to ensure your designated Patient Service Center is operational.

Hide
Quest Diagnostics

Malignant Pericardial Effusion from Cervical Squamous Cell Carcinoma: A Case Study

Malignant Pericardial Effusion from Cervical Squamous Cell Carcinoma: A Case Study

Authors: Sham S, Geetha SD, Kawam A, Bendari A, Al-Refai R, Anjali FNU, Harshan M, Das K

Citation: Am J Case Rep. 2024 Aug 28;25:e943013. doi: 10.12659/AJCR.943013.

Specialties: Oncology, Cardiology

Disclaimer: One or more of the authors of this publication were employed at the time by AmeriPath Diagnostics, a subsidiary of Quest Diagnostics.

Related content

Publication
S3 guideline for actinic keratosis and cutaneous squamous cell carcinoma
Publication
Contributions of Liquid Based Papanicolaou Cytology and Human Papillomavirus Testing in Cotesting for Detection of Cervical Cancer and Precancer in the United States
Audio Podcast
Exploring Digital Pathology and Artificial Intelligence

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.